Wird geladen...
Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches
Precision oncology is now the evidence-based standard of care for the management of many advanced non-small cell lung cancers (NSCLCs). Expert consensus has defined minimum requirements for routine testing and identification of epidermal growth factor (EGFR) mutations (15% of tumors harbor EGFR exon...
Gespeichert in:
| Veröffentlicht in: | Ther Adv Respir Dis |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publications
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5933559/ https://ncbi.nlm.nih.gov/pubmed/26620497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753465815617871 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|